The Journal of Experimental Medicine
FluoroSpot from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online June 4, 2007
doi:10.1084/jem.20062694
The Journal of Experimental Medicine, Vol. 204, No. 6, 1475-1485
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Reiley et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4112K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reiley, W. W.
Right arrow Articles by Sun, S.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reiley, W. W.
Right arrow Articles by Sun, S.-C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses

William W. Reiley1, Wei Jin1, Andrew Joon Lee1, Ato Wright1, Xuefeng Wu1, Eric F. Tewalt1, Timothy O. Leonard2, Christopher C. Norbury1, Leo Fitzpatrick3, Minying Zhang1, and Shao-Cong Sun1

1 Department of Microbiology and Immunology, 2 Department of Pathology, and 3 Department of Surgery, Pennsylvania State University College of Medicine, Hershey, PA 17033

CORRESPONDENCE Shao-Cong Sun: sxs70{at}psu.edu

The deubiquitinating enzyme CYLD has recently been implicated in the regulation of signal transduction, but its physiological function and mechanism of action are still elusive. In this study, we show that CYLD plays a pivotal role in regulating T cell activation and homeostasis. T cells derived from Cyld knockout mice display a hyperresponsive phenotype and mediate the spontaneous development of intestinal inflammation. Interestingly, CYLD targets a ubiquitin-dependent kinase, transforming growth factor–ß-activated kinase 1 (Tak1), and inhibits its ubiquitination and autoactivation. Cyld-deficient T cells exhibit constitutively active Tak1 and its downstream kinases c-Jun N-terminal kinase and I{kappa}B kinase ß. These results emphasize a critical role for CYLD in preventing spontaneous activation of the Tak1 axis of T cell signaling and, thereby, maintaining normal T cell function.


Abbreviations used: DUB, deubiquitinating enzyme; EMSA, electrophoresis mobility shift assay; ERK, extracellular-regulated kinase; GST, glutathione S-transferase; IB, immunoblotting; IBD, inflammatory bowel disease; IKK, I{kappa}B kinase; IP, immunoprecipitation; JNK, c-Jun N-terminal kinase; Tak1, TGF-ß–activated kinase 1.

W. W. Reiley and W. Jin contributed equally to this paper.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS